Cinven acquires majority stake in Synlab AG
Cinven has secured 79% of all outstanding shares of Synlab AG, a Frankfurt-listed medical diagnostic services and speciality testing firm.
Cinven has secured 79% of all outstanding shares of Synlab AG, a Frankfurt-listed medical diagnostic services and speciality testing firm.